Vitamin C, Zinc and Vitamin B12: study protocols
8 study groups took Vitamin C together with Zinc and Vitamin B12. These are the doses the studies gave. They are not a recommendation.
Dose per serving from research: Vitamin C
8 study groups in 7 studies say how much Vitamin C participants took a day.
These are the doses the studies gave. They are not a recommendation.
Most common: 100 mg to 250 mg, 50% of 8 study groups.
| Daily dose | Study groups |
|---|---|
| 50 mg or less | 1 |
| 50 mg to 100 mg | 1 |
| 100 mg to 250 mg | 4 |
| 250 mg to 500 mg | 2 |
Dose per serving from research: Zinc
8 study groups in 7 studies say how much Zinc participants took a day.
These are the doses the studies gave. They are not a recommendation.
Most common: 10 mg to 25 mg, 50% of 8 study groups.
| Daily dose | Study groups |
|---|---|
| 5 mg to 10 mg | 3 |
| 10 mg to 25 mg | 4 |
| 25 mg to 50 mg | 1 |
Dose per serving from research: Vitamin B12
8 study groups in 7 studies say how much Vitamin B12 participants took a day.
These are the doses the studies gave. They are not a recommendation.
Most common: 1 mcg to 2.5 mcg, 38% of 8 study groups.
| Daily dose | Study groups |
|---|---|
| 1 mcg to 2.5 mcg | 3 |
| 2.5 mcg to 5 mcg | 2 |
| 5 mcg to 10 mcg | 2 |
| 10 mcg to 25 mcg | 0 |
| 25 mcg to 50 mcg | 0 |
| 50 mcg to 100 mcg | 0 |
| 100 mcg to 250 mcg | 0 |
| 250 mcg to 500 mcg | 0 |
| 500 mcg to 1 mg | 0 |
| 1 mg to 2.5 mg | 0 |
| 2.5 mg to 5 mg | 0 |
| 5 mg to 10 mg | 0 |
| 10 mg to 25 mg | 1 |
Commonly used together
8 of 8 study groups took Vitamin C, Zinc and Vitamin B12 with something else. Shown: what 3 or more different studies gave.
What was given together, not what works together.
| Taken with | Study groups |
|---|---|
| Vitamin B6 | 7 |
| Folic Acid | 5 |
| Vitamin D | 5 |
| Vitamin E | 5 |
| Magnesium | 3 |
| Riboflavin | 3 |
| Thiamine | 3 |
8 study groups
| Study | |||||
|---|---|---|---|---|---|
| Effects of high-dose B vitamin complex with vitamin C and minerals on subjective mood and performance in healthy males 2010 · multi-vitamin/mineral · Healthy males aged 30–55 years in full-time employment | 500 mg | 10 mg | 10 mcg | 33 days | 103 |
| Effects of multimicronutrient supplementation on helminth reinfection: a randomized, controlled trial in Kenyan schoolchildren 2003 · multimicronutrient supplementation · Schoolchildren in Nyanza Province, Kenya; age and sex not specified | 50 mg | 20 mg | 2 mcg | 335 days | — |
| Effects of maternal micronutrient supplementation on fetal loss and infant mortality: a cluster-randomized trial in Nepal 2003 · Multiple micronutrients · Pregnant women in rural Nepal | 100 mg | 30 mg | 2.6 mcg | — | — |
| Effects of Macuprev(®) Supplementation in Age-Related Macular Degeneration: A Double-Blind Randomized Morpho-Functional Study Along 6 Months of Follow-Up 2019 · AMD-M group · Adults with intermediate age-related macular degeneration; 9 male and 21 female enrolled overall, mean age 69.32 years | 160 mg | 16 mg | 18 mg | 26 weeks | 15 |
| Improving neuropathy scores in type 2 diabetic patients using micronutrients supplementation 2011 · Group MVB · Patients with type 2 diabetes | 200 mg | 20 mg | 10 mcg | 120 days | — |
| Effects of Multivitamin, Multimineral and Phytonutrient Supplementation on Nutrient Status and Biomarkers of Heart Health Risk in a Russian Population: A Randomized, Double Blind, Placebo Controlled Study 2018 · VMP (Nutrilite Double X™) · Generally healthy adults aged 40–70 years in Moscow with low habitual recommended-food intake (recommended food score <12), predominantly women; no chronic diseases | 180 mg | 6 mg | 2 mcg | 8 weeks | 60 |
| Use of Nutraceuticals in Elderly to Fight Inflammation and Immuno-Senescence: A Randomized Case-Control Study 2022 · TG1 · Hospitalized adults older than 65 years; sex not restricted; recruited for causes other than cancer, with specified immune-disease and infection exclusions | 135 mg | 7.5 mg | 2.5 mcg | 12 weeks | 30 |
| Use of Nutraceuticals in Elderly to Fight Inflammation and Immuno-Senescence: A Randomized Case-Control Study 2022 · TG2 · Hospitalized adults older than 65 years; sex not restricted; recruited for causes other than cancer, with specified immune-disease and infection exclusions | 270 mg | 15 mg | 5 mcg | 6 weeks | 30 |